Citius Oncology, Inc. Common Stock
$0.6755
USD
Last updated on --.
24h volume40.49K
24h highest0.71200 USD
24h lowest0.66300 USD
24h Price movement-2.45%
CTOR recent prices
24 Hours
-2.45%-$0.017
30 days
-30.59%-$0.3019
60 days
+0.78%+$0.0053
90 days
-15.07%-$0.1224
Key data
Previous close0.69250 USD
Market cap72.53M USD
Volume40.49K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-0.46000 USD
Net income (FY)-42.51M USD
Revenue (FY)5.61M USD
Last report dateMay 15, 2026
About Citius Oncology, Inc. Common Stock
HeadquartersCRANFORD
Listed onNasdaq
CTOR conversion tables
 |  |
|---|---|
| 0.5 CTOR | 0.33775 USD |
| 1 CTOR | 0.6755 USD |
| 5 CTOR | 3.377 USD |
| 10 CTOR | 6.755 USD |
| |
|---|---|
| 0.5 USD | 0.74019 CTOR |
| 1 USD | 1.480 CTOR |
| 5 USD | 7.401 CTOR |
| 10 USD | 14.8 CTOR |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
CTOR is trading at $0.6755, -2.45% over the last 24 hours. Track live moves on the price chart at the top of this page.
The CTOR stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. CTOR is currently trading at $0.6755, -2.45% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on CTOR price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. CTOR's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from CTOR; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against CTOR's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Citius Oncology, Inc. Common Stock's market cap is currently 72.53M USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume40.49K
24h highest0.71200 USD
24h lowest0.66300 USD
24h Price movement-2.45%
Start trade with CTOR Perpetual
Sign up to trade